Skip to content

Tigertriever 17 Revascularization Device TRPP7166Recalls & reported problems

Rapid Medical Ltd · The Tigertriever device is a stentriever that is comprised of an adjustable nitinol braided mesh, stainless steel shaft, nitinol core wire and a handle. The shaft connects the mesh and the handle by the core wire that runs inside the shaft from the distal end of the mesh to the slider activation element in the handle. The mesh is expanded when the physician pulls the slider, since the wires of the mesh are completely radiopaque, the physician sees the mesh under fluoroscopy and controls it until it conforms to the vessel diameter. The design of the wire mesh is optimized to penetrate the clot and encapsulate it during retrieval. Two versions of the device are available. The standard version Tigertriever (TRPP7155) has a net length of 32mm (unexpanded form) and it is delivered through a microcatheter with an internal diameter of 0.021 inches. The shorter version Tigertriever 17 (TRPP7166) has a net length of 23 mm (unexpanded form) and it is delivered through a microcatheter with an internal diameter of 0.017 inches. The Tigertriever is provided with a 3.5 Fr peelable loading sheath. · Class 2

Adverse event reports
5
Deaths reported
2
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 07290015107273), received between Jun 16, 2022 and May 6, 2025 — classified as 2 deaths, 3 injuries.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 2 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 1 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem5

Patient problems

  • Intracranial Hemorrhage2
  • Vascular Dissection2
  • Hemorrhage/Blood Loss/Bleeding1

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 6, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A 49-YEAR-OLD FEMALE IN THE COGNITIVE POST-MARKET STUDY PRESENTED WITH A RIGHT M1 OCCLUSION AND UNDERWENT THROMBECTOMY USING THE TIGERTRIEVER 17 WITH ASPIRATION, ACHIEVING TICI 2C AFTER MULTIPLE PASSES. POST-PROCEDURE IMAGING REVEALED A SUBARACHNOID HEMORRHAGE, WHICH WAS PROMPTLY MANAGED WITHOUT FURTHER COMPLICATIONS. THE PATIENT RECOVERED WELL (NIHSS 0 AT 24H) AND WAS DISCHARGED FOR REHABILITATION.

    Patient problems: Hemorrhage/Blood Loss/Bleeding

    MAUDE report 21966076 ↗
  • DeathNov 30, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    RAPID MEDICAL RECEIVED A REPORT REGARDING THE TIGERTRIEVER 17 DEVICE WHICH WAS USED FOR AN ACUTE ISCHEMIC STROKE. AFTER SUCCESSFUL REMOVAL OF A THROMBUS FROM THE ACA, THE DEVICE WAS DIRECTED INTO THE PROXIMAL MCA SEGMENT. WHEN TRYING TO DEFLATE THE DEVICE, NO REACTION WAS DETECTED. WHEN REMOVAL WAS ATTEMPTED, RESISTANCE WAS MET. ULTIMATELY THE DEVICE WAS SUCCESSFULLY REMOVED, HOWEVER A DISSECTION WAS SUBSEQUENTLY OBSERVED. AS A RESULT, HEMORRHAGING WAS NOTED IN THE AREA OF TREATMENT AND THE PATIENT ULTIMATELY EXPIRED.

    Patient problems: Vascular Dissection

    MAUDE report 18238546 ↗
  • DeathNov 30, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    RAPID MEDICAL RECEIVED A REPORT REGARDING THE TIGERTRIEVER 17 DEVICE WHICH WAS USED FOR AN ACUTE ISCHEMIC STROKE. AFTER SUCCESSFUL REMOVAL OF A THROMBUS FROM THE ACA, THE DEVICE WAS DIRECTED INTO THE PROXIMAL MCA SEGMENT. WHEN TRYING TO DEFLATE THE DEVICE, NO REACTION WAS DETECTED. WHEN REMOVAL WAS ATTEMPTED, RESISTANCE WAS MET. ULTIMATELY THE DEVICE WAS SUCCESSFULLY REMOVED, HOWEVER A DISSECTION WAS SUBSEQUENTLY OBSERVED. AS A RESULT, HEMORRHAGING WAS NOTED IN THE AREA OF TREATMENT AND THE PATIENT ULTIMATELY EXPIRED.

    Patient problems: Vascular Dissection

    MAUDE report 18235612 ↗
  • InjuryJul 4, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED BY A HEALTHCARE PROFESSIONAL THAT A PATIENT UNDERWENT MECHANICAL THROMBECTOMY OF RIGHT MCA (2ND DIVISION) OCCLUSION WITH A TIGERTRIEVER 17 AND EXPERIENCED A SUBARACHNOID HEMORRHAGE (SAH) POST-PROCEDURE. THE PATIENT HAD A PREVIOUS STROKE IN THIS AREA. PREVIOUS TREATMENT APPROXIMATELY 2 DAYS PRIOR. A TOTAL OF SIX PASSES WERE MADE, 1ST AND 6TH PASSES WERE COMBINATION TIGERTRIEVER 17 AND ASPIRATION. PASSES 2-5 WERE DIRECT ASPIRATION ALONE. THERE WAS NO ALLEGATION AGAINST THE TIGERTRIEVER 17 DEVICE. NO ADDITIONAL TREATMENT OR INTERVENTION WAS REPORTED. TICI 2A WAS ACHIEVED. THE HEALTHCARE PROFESSIONAL DETERMINED THE EVENT WAS PROBABLY PROCEDURE RELATED AND MAY BE RELATED TO THE TIGERTRIEVER 17 DEVICE.

    Patient problems: Intracranial Hemorrhage

    MAUDE report 14904006 ↗
  • InjuryJun 16, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED BY A HEALTHCARE PROFESSIONAL THAT A PATIENT UNDERWENT MECHANICAL THROMBECTOMY OF RIGHT MCA (2ND DIVISION) OCCLUSION WITH A TIGERTRIEVER 17 AND EXPERIENCED A SUBARACHNOID HEMORRHAGE (SAH) POST-PROCEDURE. THE PATIENT HAD A PREVIOUS STROKE IN THIS AREA. PREVIOUS TREATMENT APPROXIMATELY 2 DAYS PRIOR. A TOTAL OF SIX PASSES WERE MADE, 1ST AND 6TH PASSES WERE COMBINATION TIGERTRIEVER 17 AND ASPIRATION. PASSES 2-5 WERE DIRECT ASPIRATION ALONE. THERE WAS NO ALLEGATION AGAINST THE TIGERTRIEVER 17 DEVICE. NO ADDITIONAL TREATMENT OR INTERVENTION WAS REPORTED. TICI 2A WAS ACHIEVED. THE HEALTHCARE PROFESSIONAL DETERMINED THE EVENT WAS PROBABLY PROCEDURE RELATED AND MAY BE RELATED TO THE TIGERTRIEVER 17 DEVICE.

    Patient problems: Intracranial Hemorrhage

    MAUDE report 14711850 ↗

Other Catheter, Thrombus Retriever devices

All Catheter, Thrombus Retriever devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.